EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 106 filers reported holding EPIZYME INC in Q3 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $43,000 | -38.6% | 37,606 | +35.3% | 0.00% | – |
Q4 2021 | $70,000 | -65.5% | 27,797 | -29.8% | 0.00% | – |
Q3 2021 | $203,000 | -35.4% | 39,588 | +4.6% | 0.00% | – |
Q2 2021 | $314,000 | -6.0% | 37,853 | -1.5% | 0.00% | – |
Q1 2021 | $334,000 | -18.1% | 38,448 | +2.3% | 0.00% | – |
Q4 2020 | $408,000 | +7.1% | 37,572 | +17.6% | 0.00% | – |
Q3 2020 | $381,000 | -30.0% | 31,961 | -5.8% | 0.00% | – |
Q2 2020 | $544,000 | -28.8% | 33,917 | -31.2% | 0.00% | -100.0% |
Q1 2020 | $764,000 | -46.2% | 49,290 | -14.6% | 0.00% | 0.0% |
Q4 2019 | $1,419,000 | +511.6% | 57,688 | +156.6% | 0.00% | – |
Q3 2019 | $232,000 | +51.6% | 22,479 | +84.7% | 0.00% | – |
Q2 2019 | $153,000 | +13.3% | 12,169 | +11.3% | 0.00% | – |
Q1 2019 | $135,000 | +20.5% | 10,934 | +3.9% | 0.00% | – |
Q3 2018 | $112,000 | -18.8% | 10,521 | +3.4% | 0.00% | – |
Q2 2018 | $138,000 | -26.2% | 10,175 | -3.2% | 0.00% | – |
Q1 2018 | $187,000 | -89.8% | 10,508 | -89.1% | 0.00% | -100.0% |
Q3 2017 | $1,834,000 | +27.1% | 96,248 | +0.7% | 0.00% | +100.0% |
Q2 2017 | $1,443,000 | -10.7% | 95,572 | +1.5% | 0.00% | -50.0% |
Q1 2017 | $1,615,000 | +42.5% | 94,173 | +0.5% | 0.00% | +100.0% |
Q4 2016 | $1,133,000 | +28.0% | 93,658 | +4.2% | 0.00% | 0.0% |
Q3 2016 | $885,000 | +6.5% | 89,924 | +10.8% | 0.00% | 0.0% |
Q2 2016 | $831,000 | -16.9% | 81,178 | -1.6% | 0.00% | 0.0% |
Q1 2016 | $1,000,000 | -25.0% | 82,488 | -0.8% | 0.00% | -50.0% |
Q4 2015 | $1,333,000 | +24.7% | 83,179 | +0.1% | 0.00% | 0.0% |
Q3 2015 | $1,069,000 | -45.5% | 83,056 | +1.6% | 0.00% | -33.3% |
Q2 2015 | $1,962,000 | +41.4% | 81,763 | +10.6% | 0.00% | +50.0% |
Q1 2015 | $1,388,000 | +0.1% | 73,900 | +0.5% | 0.00% | 0.0% |
Q4 2014 | $1,387,000 | -29.5% | 73,500 | +1.2% | 0.00% | -33.3% |
Q3 2014 | $1,968,000 | -14.3% | 72,600 | -1.6% | 0.00% | -25.0% |
Q2 2014 | $2,297,000 | +36.7% | 73,800 | 0.0% | 0.00% | +33.3% |
Q1 2014 | $1,680,000 | +2.1% | 73,800 | +80.0% | 0.00% | 0.0% |
Q3 2013 | $1,645,000 | +42.7% | 41,000 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $1,153,000 | – | 41,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |